nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Hepatitis cholestatic—Montelukast—chronic obstructive pulmonary disease	0.0353	0.0359	CcSEcCtD
Carbimazole—Emotional distress—Salbutamol—chronic obstructive pulmonary disease	0.0323	0.0328	CcSEcCtD
Carbimazole—Foetor hepaticus—Montelukast—chronic obstructive pulmonary disease	0.0251	0.0255	CcSEcCtD
Carbimazole—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.0209	0.0212	CcSEcCtD
Carbimazole—Contusion—Montelukast—chronic obstructive pulmonary disease	0.0163	0.0166	CcSEcCtD
Carbimazole—Mouth ulceration—Tiotropium—chronic obstructive pulmonary disease	0.0163	0.0166	CcSEcCtD
Carbimazole—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.0142	0.0145	CcSEcCtD
Carbimazole—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0116	0.0118	CcSEcCtD
Carbimazole—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0114	0.0116	CcSEcCtD
Carbimazole—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.0113	0.0115	CcSEcCtD
Carbimazole—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.0112	0.0114	CcSEcCtD
Carbimazole—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.0108	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.0108	CcSEcCtD
Carbimazole—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0105	0.0107	CcSEcCtD
Carbimazole—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0101	0.0103	CcSEcCtD
Carbimazole—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.01	0.0102	CcSEcCtD
Carbimazole—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00991	0.0101	CcSEcCtD
Carbimazole—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00981	0.00998	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0093	0.00946	CcSEcCtD
Carbimazole—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00883	0.00899	CcSEcCtD
Carbimazole—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00847	0.00861	CcSEcCtD
Carbimazole—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00841	0.00856	CcSEcCtD
Carbimazole—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.0082	0.00834	CcSEcCtD
Carbimazole—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.00815	0.00829	CcSEcCtD
Carbimazole—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00811	0.00825	CcSEcCtD
Carbimazole—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00776	0.00789	CcSEcCtD
Carbimazole—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00752	0.00765	CcSEcCtD
Carbimazole—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00748	0.00761	CcSEcCtD
Carbimazole—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00748	0.00761	CcSEcCtD
Carbimazole—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00719	0.00731	CcSEcCtD
Carbimazole—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00714	0.00727	CcSEcCtD
Carbimazole—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00692	0.00704	CcSEcCtD
Carbimazole—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00689	0.007	CcSEcCtD
Carbimazole—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00676	0.00688	CcSEcCtD
Carbimazole—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0067	0.00681	CcSEcCtD
Carbimazole—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0067	0.00681	CcSEcCtD
Carbimazole—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00668	0.00679	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00665	0.00677	CcSEcCtD
Carbimazole—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00655	0.00666	CcSEcCtD
Carbimazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00644	0.00655	CcSEcCtD
Carbimazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00643	0.00654	CcSEcCtD
Carbimazole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00639	0.00651	CcSEcCtD
Carbimazole—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00638	0.00649	CcSEcCtD
Carbimazole—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0063	0.0064	CcSEcCtD
Carbimazole—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.00636	CcSEcCtD
Carbimazole—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00624	0.00634	CcSEcCtD
Carbimazole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00606	0.00617	CcSEcCtD
Carbimazole—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00589	0.00599	CcSEcCtD
Carbimazole—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00589	0.00599	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00585	0.00595	CcSEcCtD
Carbimazole—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0058	0.0059	CcSEcCtD
Carbimazole—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0058	0.0059	CcSEcCtD
Carbimazole—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00572	0.00582	CcSEcCtD
Carbimazole—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00572	0.00582	CcSEcCtD
Carbimazole—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00568	0.00578	CcSEcCtD
Carbimazole—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00556	0.00566	CcSEcCtD
Carbimazole—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00548	0.00557	CcSEcCtD
Carbimazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00541	0.0055	CcSEcCtD
Carbimazole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00541	0.0055	CcSEcCtD
Carbimazole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0054	0.0055	CcSEcCtD
Carbimazole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0054	0.0055	CcSEcCtD
Carbimazole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0054	0.0055	CcSEcCtD
Carbimazole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0054	0.0055	CcSEcCtD
Carbimazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00538	0.00547	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00537	0.00546	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00537	0.00546	CcSEcCtD
Carbimazole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00534	0.00543	CcSEcCtD
Carbimazole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00534	0.00543	CcSEcCtD
Carbimazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00529	0.00539	CcSEcCtD
Carbimazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00529	0.00539	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00526	0.00535	CcSEcCtD
Carbimazole—Infection—Formoterol—chronic obstructive pulmonary disease	0.00515	0.00524	CcSEcCtD
Carbimazole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00515	0.00524	CcSEcCtD
Carbimazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.0051	0.00519	CcSEcCtD
Carbimazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.0051	0.00519	CcSEcCtD
Carbimazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0051	0.00519	CcSEcCtD
Carbimazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00508	0.00517	CcSEcCtD
Carbimazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00508	0.00517	CcSEcCtD
Carbimazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00504	0.00513	CcSEcCtD
Carbimazole—Infection—Montelukast—chronic obstructive pulmonary disease	0.00504	0.00513	CcSEcCtD
Carbimazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00503	0.00512	CcSEcCtD
Carbimazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00503	0.00512	CcSEcCtD
Carbimazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00502	0.0051	CcSEcCtD
Carbimazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00498	0.00506	CcSEcCtD
Carbimazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00497	0.00505	CcSEcCtD
Carbimazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00493	0.00501	CcSEcCtD
Carbimazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00486	0.00494	CcSEcCtD
Carbimazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00482	0.0049	CcSEcCtD
Carbimazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0048	0.00488	CcSEcCtD
Carbimazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00475	0.00483	CcSEcCtD
Carbimazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00473	0.00481	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00472	0.0048	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00472	0.0048	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00462	0.0047	CcSEcCtD
Carbimazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00454	0.00462	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00446	0.00453	CcSEcCtD
Carbimazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00429	0.00437	CcSEcCtD
Carbimazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00429	0.00436	CcSEcCtD
Carbimazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00427	0.00434	CcSEcCtD
Carbimazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00427	0.00434	CcSEcCtD
Carbimazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00426	0.00434	CcSEcCtD
Carbimazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00412	0.00419	CcSEcCtD
Carbimazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00412	0.00419	CcSEcCtD
Carbimazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0041	0.00417	CcSEcCtD
Carbimazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0041	0.00417	CcSEcCtD
Carbimazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00405	0.00412	CcSEcCtD
Carbimazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00404	0.00411	CcSEcCtD
Carbimazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00404	0.00411	CcSEcCtD
Carbimazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00403	0.0041	CcSEcCtD
Carbimazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00403	0.0041	CcSEcCtD
Carbimazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00402	0.00409	CcSEcCtD
Carbimazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00401	0.00408	CcSEcCtD
Carbimazole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00397	0.00404	CcSEcCtD
Carbimazole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00395	0.00402	CcSEcCtD
Carbimazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.00395	CcSEcCtD
Carbimazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00387	0.00393	CcSEcCtD
Carbimazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00382	0.00388	CcSEcCtD
Carbimazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00382	0.00388	CcSEcCtD
Carbimazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00381	0.00388	CcSEcCtD
Carbimazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00374	0.0038	CcSEcCtD
Carbimazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00373	CcSEcCtD
Carbimazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00373	CcSEcCtD
Carbimazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0036	0.00367	CcSEcCtD
Carbimazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00359	0.00365	CcSEcCtD
Carbimazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00352	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00335	0.00341	CcSEcCtD
Carbimazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.00332	CcSEcCtD
Carbimazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.00327	0.00332	CcSEcCtD
Carbimazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00326	0.00332	CcSEcCtD
Carbimazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00326	0.00332	CcSEcCtD
Carbimazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.0033	CcSEcCtD
Carbimazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.00325	0.0033	CcSEcCtD
Carbimazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.0032	0.00326	CcSEcCtD
Carbimazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0032	0.00325	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00319	0.00325	CcSEcCtD
Carbimazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.00318	0.00323	CcSEcCtD
Carbimazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00314	0.0032	CcSEcCtD
Carbimazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.0031	0.00315	CcSEcCtD
Carbimazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00314	CcSEcCtD
Carbimazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00313	CcSEcCtD
Carbimazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00313	CcSEcCtD
Carbimazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00313	CcSEcCtD
Carbimazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00306	0.00312	CcSEcCtD
Carbimazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00301	0.00307	CcSEcCtD
Carbimazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00296	CcSEcCtD
Carbimazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.00294	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00288	0.00293	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00287	0.00292	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.0026	0.00265	CcSEcCtD
Carbimazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00254	0.00258	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00232	0.00236	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Carbimazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00228	0.00232	CcSEcCtD
Carbimazole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00229	CcSEcCtD
Carbimazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00223	0.00227	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00216	CcSEcCtD
Carbimazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00216	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00211	0.00215	CcSEcCtD
Carbimazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.0021	0.00214	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00207	0.0021	CcSEcCtD
Carbimazole—Infection—Prednisone—chronic obstructive pulmonary disease	0.00203	0.00206	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—APIP—chronic obstructive pulmonary disease	0.00202	0.118	CbGpPWpGaD
Carbimazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.002	0.00203	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00201	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00186	0.00189	CcSEcCtD
Carbimazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.0018	CcSEcCtD
Carbimazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.0018	CcSEcCtD
Carbimazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Carbimazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.0017	CcSEcCtD
Carbimazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00165	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00164	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.0016	0.0934	CbGpPWpGaD
Carbimazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00153	CcSEcCtD
Carbimazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00147	CcSEcCtD
Carbimazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00131	CcSEcCtD
Carbimazole—Headache—Prednisone—chronic obstructive pulmonary disease	0.00128	0.0013	CcSEcCtD
Carbimazole—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00123	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00121	0.0708	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—chronic obstructive pulmonary disease	0.000819	0.0479	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GCLC—chronic obstructive pulmonary disease	0.000703	0.0411	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—chronic obstructive pulmonary disease	0.000599	0.0351	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000555	0.0325	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TGFB1—chronic obstructive pulmonary disease	0.00055	0.0322	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—chronic obstructive pulmonary disease	0.00048	0.0281	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000459	0.0269	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000449	0.0263	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000443	0.0259	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6—chronic obstructive pulmonary disease	0.000415	0.0243	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000403	0.0236	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APIP—chronic obstructive pulmonary disease	0.000371	0.0217	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000364	0.0213	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.0191	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000322	0.0188	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.0155	CbGpPWpGaD
Carbimazole—TPO—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000246	0.0144	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GC—chronic obstructive pulmonary disease	0.000239	0.014	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000233	0.0136	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00023	0.0135	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000222	0.013	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.0113	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.0112	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000164	0.00957	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000161	0.00944	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000159	0.00931	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000148	0.00867	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000146	0.00856	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00822	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.00014	0.00819	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00811	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000131	0.00764	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000129	0.00755	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000118	0.00689	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000113	0.00662	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00635	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.05e-05	0.0053	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.92e-05	0.00522	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.31e-05	0.00487	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.06e-05	0.00472	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.00461	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.49e-05	0.00438	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.42e-05	0.00435	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.3e-05	0.00428	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	7.28e-05	0.00426	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.77e-05	0.00396	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.57e-05	0.00385	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.52e-05	0.00323	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.39e-05	0.00316	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—chronic obstructive pulmonary disease	5.36e-05	0.00314	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—chronic obstructive pulmonary disease	5.13e-05	0.003	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.98e-05	0.00233	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.93e-05	0.0023	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.67e-05	0.00215	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.59e-05	0.0021	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.31e-05	0.00194	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.76e-05	0.00161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.72e-05	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.00148	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.00141	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.63e-05	0.000956	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.000914	CbGpPWpGaD
